Company Filing History:
1 out of 107 
1 out of 7 
1 out of 3,684 
Years Active: 2022-2025
Title: Innovations by Inventor Anthony Cao
Introduction
Anthony Cao is a notable inventor based in Sammamish, Washington, who has made significant contributions to the field of cancer treatment. With a total of two patents to his name, his work focuses on innovative methods that combine various antibodies to enhance therapeutic efficacy against cancer.
Latest Patents
One of Anthony Cao's latest patents involves methods of treating cancer using a combination of an anti-PD-1 antibody and an anti-tissue factor antibody-drug conjugate. This invention provides an anti-PD-1 antibody that includes the complementary determining regions (CDRs) of pembrolizumab, combined with an antibody-drug conjugate that binds to tissue factor (TF). This combination is particularly effective in treating cancers such as breast cancer and cervical cancer. Additionally, he has developed methods for using an anti-PD-1 antibody in conjunction with an anti-CD30 antibody for tumor treatment, specifically targeting lymphomas, including Hodgkin and non-Hodgkin lymphoma.
Career Highlights
Throughout his career, Anthony has worked with prominent companies in the biotechnology sector, including Genmab and MSD International GmbH. His experience in these organizations has contributed to his expertise in developing innovative cancer therapies.
Collaborations
Anthony has collaborated with several professionals in his field, including Reshma Abdulla Rangwala and Esther C. W. Breij. These collaborations have likely enriched his research and development efforts.
Conclusion
Anthony Cao's contributions to cancer treatment through his innovative patents demonstrate his commitment to advancing medical science. His work continues to pave the way for new therapeutic strategies in oncology.